CoagTrak Anticoagulation Management Software (AMS) Receives Veracode’s
Highest Possible “A” Security Rating
Veracode Verifies CoagTrak Software as Exceeding Security Best Practices
NEW WINDSOR, NY -- (Marketwire - February 4, 2009)
- - Medimatics, LLC, the premier web-based anticoagulation management solution for private practices and hospital settings, today announced it received Veracode's highest rating "A" for its application security level.
"We decided to include Veracode's caliber and rigor of testing into our product development life cycle, to insure, and independently validate, the security of the CoagTrak platform," said Steve Larmon, CTO at CoagTrak.
"Our inclusion of this type of testing and the pursuant results truly differentiate Medimatics and the CoagTrak product as the most secure anticoagulation software in the marketplace, " commented James Gary, CoagTrak's COO, "ultimately it gives our clients the assurance we are doing everything possible to protect their patient's information."
"Today's enterprise applications containing Personally Identifiable Information (PII) and Personal Health Information (PHI) are increasingly under siege given the data is a valuable currency to attackers," said Matt Moynahan, CEO of Veracode. "Independent proof that software has been evaluated for security vulnerabilities is a competitive differentiator and demonstrates due care has been taken to meet stringent regulatory and compliance requirements. Medimatics has taken proactive steps to protect their customer's sensitive data and has demonstrated the security quality of their software through the Veracode SecurityReview service."
The Veracode rating shows that applications have been tested against industry-standard benchmarks such as Common Weakness Enumeration - CWE; Common Vulnerability Scoring System - CVSS; and the National Institute of Standards and Technology - NIST; to determine weaknesses and severity levels. The ratings incorporate business risk, so that high assurance applications, such as CoagTrak, are rigorously evaluated in context to the data they handle. This empowers enterprises to make informed risk-based decisions concerning software use and acceptance.
About Medimatics, LLC
Medimatics, the developers of CoagTrak, delivers its anticoagulation software as a service (SaaS) to a nationwide customer base encompassing cardiovascular, hematology, oncology, family practitioners, multi-specialty practices and hospitals managing anticoagulation patients. For more information, visit www.coagtrak.com, e-mail email@example.com, or call 800.293.3730.
Veracode is the world's leader for on-demand application security testing solutions. Veracode SecurityReview is the industry's first solution to use patented binary code analysis and dynamic web analysis to uniquely assess any application security threats, including vulnerabilities such as cross-site scripting (XSS), SQL injection, buffer overflows and malicious code. SecurityReview performs the only complete and independent security audit across any internally developed applications, third-party commercial off-the-shelf software and offshore code without exposing a company's source code. Delivered as an on-demand service, Veracode delivers the simplest and most-cost effective way to implement security best practices, reduce operational cost and achieve regulatory requirements such as PCI compliance without requiring any hardware, software or training.
Based in Burlington, Mass., Veracode is backed by .406 Ventures, Atlas Venture and Polaris Venture Partners. For more information, visit www.veracode.com.
Copyright © 2009 Medimatics, LLC. Developers of CoagTrak,
Anticoagulation Management Software (AMS). All rights reserved. CoagTrak and
the CoagTrak logo are service-marks of Medimatics LLC., Other marks are the property
of their respective owners.
Medimatics, LLC, developers of CoagTrak
« View All News Items